Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trollfors

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Vaccine|September 3, 2013
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experienceBirgit Thierry-Carstensen, Tine Dalby, Michael A Stevner, et al.
The Journal of Pediatrics|April 1, 1990
Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old childrenI Krantz, R Sekura, B Trollfors, et al.
The Pediatric Infectious Disease Journal|April 16, 1998
Immunization of children with pertussis toxoid decreases spread of pertussis within the familyB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussisJ Taranger, B Trollfors, T Lagergård, et al.
Pediatric Infectious Disease|November 1, 1984
Incidence and prognosis of acute epiglottitis in children in a Swedish regionB Claesson, B Trollfors, B Ekström-Jodal, et al.
BMC Infectious Diseases|October 8, 2016
Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm)Margret Johansson Gudjónsdóttir, Karsten Kötz, Ruth Stangebye Nielsen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussisB Trollfors, J Taranger, T Lagergård, et al.
BMC Infectious Diseases|August 5, 2016
Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factorsErik Backhaus, Stefan Berg, Rune Andersson, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Vaccine|September 3, 2013
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experienceBirgit Thierry-Carstensen, Tine Dalby, Michael A Stevner, et al.
The Journal of Pediatrics|April 1, 1990
Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old childrenI Krantz, R Sekura, B Trollfors, et al.
The Pediatric Infectious Disease Journal|April 16, 1998
Immunization of children with pertussis toxoid decreases spread of pertussis within the familyB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Infectious Diseases|March 18, 2000
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussisJ Taranger, B Trollfors, T Lagergård, et al.
Pediatric Infectious Disease|November 1, 1984
Incidence and prognosis of acute epiglottitis in children in a Swedish regionB Claesson, B Trollfors, B Ekström-Jodal, et al.
BMC Infectious Diseases|October 8, 2016
Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm)Margret Johansson Gudjónsdóttir, Karsten Kötz, Ruth Stangebye Nielsen, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussisB Trollfors, J Taranger, T Lagergård, et al.
BMC Infectious Diseases|August 5, 2016
Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factorsErik Backhaus, Stefan Berg, Rune Andersson, et al.
Pageof 24